In hereditary hemochromatosis mutations in HFE lead to iron overload through abnormally low levels of hepcidin. Additionally, HFE potentially modulates cellular iron uptake by interacting with transferrin receptor, a crucial protein during erythropoiesis. However the role of HFE in this process was never explored. We hypothesize that HFE modulates erythropoiesis by affecting dietary iron absorption and erythroid iron intake. To investigate this we utilized Hfe-KO mice in conditions of altered dietary iron and erythropoiesis. We show that Hfe-KO mice can overcome phlebotomy induced anemia more rapidly than wt mice (even when iron loaded). Second, we evaluated mice combining the hemochromatosis and beta-thalassemia phenotypes. Our results suggest that lack of Hfe is advantageous in conditions of increased erythropoietic activity, due to augmented iron mobilization driven by deficient hepcidin response. Lastly, we demonstrate that Hfe is expressed in erythroid cells and impairs iron uptake, while its absence exclusively from the hematopoietic compartment is sufficient to accelerate recovery from phlebotomy. In summary, we demonstrate that Hfe influences erythropoiesis by two distinct mechanisms: limiting hepcidin expression under conditions of simultaneous iron overload and stress erythropoiesis; impairing transferrin-bound iron uptake by erythroid cells. Moreover, our results provide novel suggestions to improve the treatment of hemochromatosis.
Introduction
Iron metabolism and erythropoiesis are closely related. Delineating the mechanisms by which they cooperate and co-regulate is crucial to understanding a variety of vital physiological functions. Erythropoiesis modulates iron absorption by participating in the regulation of hepcidin 1-3 , a peptide hormone produced mainly in the liver 4, 5 . Hepcidin controls iron absorption and recycling by inducing internalization and degradation of ferroportin (Fpn1), the only known cellular iron exporter 6 . Iron demand increases with erythropoietic activity, strongly downregulating hepcidin expression [1] [2] [3] , and allowing for increased iron flow to the serum. In addition to being regulated by erythropoiesis, hepcidin expression also responds to hypoxia, iron levels and inflammation 2 . While erythropoiesis and hypoxia block hepcidin expression, inflammation and high iron levels increase it. Thus, modulation of this peptide hormone requires integration of opposing stimuli 7 . In fact, the effect of erythropoiesis can be partially impaired by iron overload and inflammation 7 .
HFE, the gene mutated in most cases of hereditary hemochromatosis (HH) 8, 9 , is thought to participate in hepcidin regulation in response to iron 10 . Iron overload in this disorder results from a failure to regulate iron absorption despite an increased iron load, leading to abnormal iron deposition in key organs if left untreated. Abnormally low hepcidin expression seems to be the major factor leading to iron overload in HH [11] [12] [13] , although the exact molecular mechanism is still not fully understood. Association of Hfe and its partners, transferrin receptor-1 (Tfrc) and -2 (Tfr2), has been suggested to activate a regulatory pathway that controls hepcidin expression in response to serum iron levels 10, 14 . However, another study hypothesized that Hfe and Tfr2 modulate hepcidin by parallel pathways 15 . Hfe has also been implicated in the regulation of transferrin-bound iron uptake. Several studies showed that Hfe competes with transferrin for the same binding sites on Tfrc thereby impairing iron uptake [16] [17] [18] [19] . Yet, despite all of the studies describing interaction of Hfe with Tfrc 19-21 , few investigated their association within the erythroid compartment, where the latter is known to be essential 22 . Earlier studies reported that Hfe could not be detected in nucleated erythroid cells 23 , and that liver specific ablation of Hfe mirrors most of the HH phenotype, indicating that it plays a pivotal role in this organ 24 . However, these studies did not include a thorough analysis of Hfe expression during erythroid maturation or directly investigate the effect of Hfe ablation on erythropoiesis. In contrast, several reports showed erythropoietic alterations in HH patients, including increased hemoglobin (Hb) levels, reticulocyte counts (Retics), hematocrit (Hct), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC) 23, 25, 26 . Additional observations demonstrated that the HFE promoter contains several
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We studied two potential functions of Hfe in erythropoiesis: 1) an indirect effect mediated by modulation of hepcidin expression under conditions of erythropoietic stress; and 2) a direct role involving modulation of erythroid iron homeostasis. Analysis of wt, Hfe-KO and thalassemic mice lacking Hfe indicates that this gene is a key player controlling hepcidin in response to iron overload at steady state, under conditions of stress erythropoiesis and even in betathalassemia. As a result, we show that Hfe contributes indirectly to increased Hb production in erythroid cells. Moreover, we demonstrate that Hfe is expressed in erythroid progenitors and interacts with Tfrc in murine erythroleukemia (MEL) cells. In its absence, the amount of Tfrc on the surface of erythroid cells was reduced, and in this way influenced iron intake. Further, transgenic expression of Hfe in the liver of Hfe-KO mice, although decreasing liver iron content, does not alter erythroid parameters such as Hb and MCH. Finally, wt mice transplanted with
Hfe-KO BM responded better to erythroid stress than wt mice transplanted with wt BM, supporting the idea that Hfe has an autonomous function in erythroid iron metabolism.
Materials and Methods

Animal care and procedures
All mice utilized were on a C57BL/6 background. For bone marrow transplantation (BMT), 5x10 6 BM cells were transplanted into lethally irradiated syngeneic recipients. Anemia was induced in 2-to 3-month-old animals either by injection of phenylhydrazine (100mg/Kg) or by phlebotomy (400μl/25g) performed under anesthesia on 3 consecutive days. An equal volume of normal saline replaced the blood removed. Complete blood counts (CBCs) were performed every 2-3 days. Some animals were fed an iron deficient diet containing 2.5-ppm of iron (Harlan-Teklad, Madison, WI), beginning 24h before the bloodletting. Iron overload in wt mice was achieved by feeding a diet supplemented with 2.5% carbonyl iron for one week. These mice were returned to a regular diet 24h prior to phlebotomy. Erythropoiesis was also stimulated by intraperitoneal administration of erythropoietin (50U/mouse/day) on 3 consecutive days. Animals were analyzed 24h after the last injection. For in vivo macrophage depletion studies, weekly intravenous injections of 0.2 ml of clodronate-containing liposomes were done for a total of 6 weeks. As a control, PBS-containing liposomes were injected into a cohort of similar animals.
Liposomes were prepared as previously described 28 .
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Lentiviral injections into the liver of pups
Aliquots of lentiviral concentrate (2x10 7 infectious particles) 29 were injected directly into the livers of 3-day-old pups, utilizing a micro injector consisting of a 100-μl nanofil syringe attached to SilFlex tubing connected to a 35-gauge beveled needle via a connector (World Precision Instruments, Sarasota, FL). Pups were placed in a supine position to visualize their livers and lentivirus was gently injected (Supplemental Figure 1A and 1B).
Immunoprecipitation and immunoblotting
Cells were lysed in RIPA buffer (150mM NaCl, 20mM Tris (pH 8.0), 1mM EDTA, 1% Triton X-100, 0.5% DOC, and 0.1% SDS) with protease and phosphatase inhibitors. After centrifugation, anti-GFP rabbit antibody (Invitrogen, Carlsbad, CA) was added and the lysates incubated for 2h at 4ºC. The immunocomplex was then precipitated using protein A-sepharose beads. After extensive washing, the complexes were eluted from the beads by boiling in 4x sample buffer for 2 minutes. Samples were then loaded in a 10% Nupage Bis-Tris Gel (Invitrogen) and transferred to PVDF membranes, followed by immunoblot analysis with anti-Tfrc antibody (Invitrogen). Immunoreactive proteins were visualized by ECL detection and film autoradiography. After striping, the membranes were reprobed with mouse anti-GFP antibody (Abgent, San Diego, CA).
Hfe detection in erythroid cells
Erythroid cells were purified from the spleens of phlebotomized mice as described 30 . Mouse erythroid colonies (CFU-E and mature BFU-E) were grown from BM in complete Methocult® medium (M3334, Stem Cell Technologies, Vancouver, BC) according to the manufacturer's instructions. Colonies were picked at day 4 or 5 of culture. RT-PCR on cDNA extracted from splenic erythroid cells or erythroid colonies was performed using specific primers for Hfe, Tfr2, Fpn1 and β -actin (Supplemental table 1 ).
Iron uptake experiments
Human apo-transferrin (Sigma) was saturated with 59 Fe (Perkin-Elmer, Waltham MA) by mixing transferrin (Tf) with a 2-fold excess of 59 FeCl 2 , a 10-fold excess of nitrilotriacetate (NTA) and 80mM NaHCO 3 . This mixture was incubated for 1h at 20 o C after which excess iron was removed using a Microcon YM-10 column. For iron uptake experiments, isolated erythroid cells were resuspended in serum free Iscove's medium, supplemented with 0.3 mg/ml of 59 Feloaded Tf, at a concentration of 10 7 cells/ml. Cells were incubated for the desired time at 37 o C.
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Statistical analysis
Statistical differences between means were calculated with Student's t test (Microsoft Excel).
Results
Hfe-KO mice show alterations in steady state hematological parameters compared to wt mice.
Several studies revealed altered red blood cell (RBC) parameters in HH patients 25, 26 , but failed to analyze erythropoiesis in detail. As a first step toward determining whether a mouse model of HH exhibits changes in erythropoiesis, we performed CBCs on wt and Hfe-KO mice at different ages. Significant differences were observed, including increases in Hb, MCV and MCH (Table 1) . Hfe-KO mice at 12 months of age had unchanged Hb values and a slight reduction in RBC counts (Table 1) . These data indicate increased Hb production in Hfe-KO RBCs, similar to the situation in HH patients. It is expected that iron overload alters erythropoiesis, since iron is essential for Hb production in RBC. Therefore, as a control for the effect of iron overload on hematological parameters, Hamp-KO mice at 2 months of age were analyzed. These mice showed no change in Hb values and smaller differences than Hfe-KO mice in MCV and MCH compared to wt mice, despite having elevated liver iron contents (Table 1) . These results indicated a potential role for Hfe in erythropoiesis apart from that in iron overload. We then looked at erythroid maturation in the BM and spleen by staining cell suspensions with an erythroid specific marker (Ter119) in combination with markers for Tfrc (CD71) and the adhesion molecule CD44 31 . Using these markers no clear differences in erythroid maturation were observed when comparing wt and Hfe-KO mice. However, we detected downregulation of Tfrc in Hfe-KO erythroid cells as indicated by a decrease in the mean fluorescence intensity (MFI) of Tfrc (Supplemental Figure 2) . Downregulation of Tfrc expression was also observed in
Hamp-KO mice (not shown), suggesting that this effect is somewhat associated with iron overload.
Hfe-KO mice respond better than wt mice to different erythropoietic stress conditions.
To determine how Hfe-KO mice respond to erythropoietic stress, we induced anemia by administration of phenylhydrazine or by phlebotomy. Recovery from both phenylhydrazineFor personal use only. on October 24, 2017. by guest www.bloodjournal.org From induced hemolytic anemia and phlebotomy was faster in Hfe-KO compared to wt mice ( Figure   1A and B). This was associated with increased Hb synthesis by Hfe-KO RBCs, as noted by increased Hb content in RBC and retics throughout the treatment (not shown). As a control, iron overloaded wt mice were utilized. Compared to Hfe-KO mice, their liver iron content was similar (not shown), their hepcidin expression was superior ( Figure 1E ) and their recovery from phlebotomy was reduced but similar to that seen in wt mice fed a regular diet ( Figure 1B) . We then determined the relative contributions of dietary and stored iron toward the response to phlebotomy in wt and Hfe-KO mice, by analyzing their recovery from anemia when fed a low iron diet. Wt mice kept on an iron deficient diet were unable to overcome the phlebotomyinduced anemia, while Hfe-KO mice fed a similar diet increased their Hb levels, although they did not fully recover ( Figure 1B ). Analysis of serum iron and transferrin saturation during the first 48 hours following phlebotomy showed that wt mice on a standard diet were able to raise their serum iron parameters very rapidly to levels similar to those of Hfe-KO mice. In contrast, wt mice fed a low iron diet showed a significant reduction of iron-related serum parameters during the same period ( Figures 1C-D) . These data suggest that 1) gastrointestinal iron absorption in both wt and Hfe-KO mice is a major factor leading to recovery from anemia; 2) iron overload in wt mice increases hepcidin levels thereby limiting utilization of stored iron in response to increased erythroid demand; and 3) low hepcidin levels in Hfe-KO mice contribute to better utilization of iron stored in the liver to increase Hb levels. Altogether, these observations support the argument that lack of Hfe improves erythropoiesis under stress conditions. The role of macrophages in erythropoiesis and iron metabolism has long been recognized 32 .
It has been suggested that interaction of macrophages with erythroblasts supports the maturation of the latter cells through a yet unknown mechanism. Additionally, macrophages are Figure 1E ). These data indicate that Hfe is not directly involved in regulation of hepcidin response to erythropoietic stimulation. However, under conditions of enhanced erythropoietic activity, hepcidin expression is inappropriately low in Hfe-KO mice, considering their iron load. This further corroborates our hypothesis that Hfe-KO mice exhibit increased iron mobilization for erythropoiesis explaining, at least in part, the increased response seen in these animals.
Combination of the hemochromatosis and thalassemic phenotypes leads to increased liver iron content and Hb levels
Our data showed that lack of Hfe is advantageous under conditions of stress. Therefore, we determined how the absence of Hfe affects a pathological condition associated with anemia and ineffective erythropoiesis, such as beta-thalassemia. We generated two groups of experimental animals utilizing mice affected by beta-thalassemia intermedia (th3/+): th3→wt mice (wt recipients engrafted with th3/+ hematopoietic stem cells (HSCs)) and th3→Hfe-KO mice (Hfe-KO recipients engrafted with th3/+ HSCs). Using these mice, we assessed how lack of Hfe in the liver affected iron distribution and hematological parameters in beta-thalassemia. Compared to wt→wt mice, th3→wt mice exhibited 4-and 4.5-fold increases in the iron content of their livers and spleens, respectively, while those in the serum were only slightly increased (Table 2 ).
In th3→Hfe-KO animals, hepatic iron overload increased dramatically (10-fold compared to wt→wt controls), while splenic iron levels were similar to those of th3/+ animals ( Table 2 ). In addition, serum iron parameters were increased compared to both wt→wt and th3→wt mice.
We also compared the hematological values in th3→wt and th3→Hfe-KO mice, observing that the latter group exhibited increased Hb levels, RBC counts and MCH (Table 2 ). This supports the observation by Ginzburg and colleagues that administration of additional iron ameliorated
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We also generated th3/+Hfe-KO mice. To determine how specific ablation of Hfe in the hematopoietic compartment affected the thalassemic phenotype, we transplanted wt mice with th3/+Hfe-KO HSCs (th3/Hfe→wt). Although these mice showed no differences in the aforementioned parameters compared to th3→wt mice (Table 2) , they did exhibit a decreased level of Tfrc on erythroid plasma membranes (not shown), similar to what we observed in Hfe-KO mice (Supplemental Figure 2 ). These data suggest that even though thalassemic erythroid cells lacking Hfe present lower levels of membrane Tfrc during their development, this does not alter their ability to produce Hb, supporting our notion that Hfe interferes with erythroid iron metabolism.
Hfe modulates hepcidin in response to iron overload in thalassemic mice
In order to evaluate the role of Hfe in modulating the response of hepcidin to iron overload in thalassemic mice, we looked at the levels of Hamp, Bmp6 (a strong modulator of hepcidin in response to iron) 36 and Id1 (another target of the Bmp/Smad pathway) 37 . All of these genes are upregulated by iron overload in wt mice 38 . Our data shows that th3→Hfe-KO mice have similar levels of hepcidin and Id1 expression compared to th3→wt and wt→wt mice, despite increased iron overload. The levels of Bmp6 were elevated in both thalassemic groups compared to wt mice. However, when the levels of hepcidin, Bmp6 and Id-1 were normalized to liver iron content, we observed that these levels were markedly reduced in th3→wt mice compared to wt animals ( Figure 3 ). After normalization, these levels were further decreased in th3→Hfe-KO mice. Collectively, these observations indicate that iron overload can partially counteract the repressive effect of ineffective erythropoiesis on hepcidin expression in beta-thalassemia.
Moreover, lack of Hfe further aggravates iron overload in thalassemic mice, indicating that Hfe plays a positive role in the regulation of hepcidin in this disorder.
Hfe is expressed in early erythroid cells and interferes with transferrin bound iron uptake
Our data shows altered RBC parameters and an increased response to erythropoietic stress Figure 4C ). Moreover, we corroborated this finding by demonstrating the expression of Hfe in erythroid colonies isolated from specific erythroid colonyforming assays ( Figure 4D ). We also looked for Hamp, Hjv, and BMPs but they were not expressed. These results argue strongly against Hfe being a sensor for hepcidin in erythroid cells, although they do not exclude completely this possibility.
To determine if Hfe interacts with Tfrc in erythroid cells, possibly interfering with iron uptake, an Hfe-GFP fusion protein was expressed in MEL cells utilizing a lentiviral vector. We observed a high degree of co-localization of Hfe-GFP and Tfrc by immunofluorescence ( Figure 5A ), and confirmed their interaction by co-immunoprecipitation ( Figure 5B ). In order to determine if Hfe affects iron uptake, we isolated wt and Hfe-KO erythroid cells, and measured iron uptake using 59 Fe-saturated transferrin. Our data showed no statistically significant difference in iron uptake between Hfe-KO and wt cells ( Figure 5C ). Interestingly, the level of Tfrc expression in Hfe-KO cells was 80% of that seen in wt cells, as measured by flow cytometry ( Figure 5D ). This was not associated with altered Tfrc recycling but instead seemed to reflect an overall decrease in Tfrc on the plasma membrane of erythroid cells (not shown). When iron uptake was normalized to the Tfrc levels it was significantly increased in Hfe-KO compared to wt cells ( Figure 5E ),
showing that Hfe-KO cells take up more iron per Tfrc. These data suggests that Hfe interferes with erythroid transferring-bound iron uptake.
Direct hepatic injection of lentiviral vectors carrying Hfe reduces the iron burden in Hfe-
KO mice with little impact on hematological parameters.
We hypothesized that expression of Hfe solely in the liver might allow us to discriminate between the role of Hfe in the hematopoietic compartment and that of iron overload in erythropoiesis. For this purpose, we developed a lentiviral vector to transduce the Hfe gene directly into the liver of Hfe-KO mice. Hepatic injection of lentiviral vectors into adult animals is quite cumbersome and not very efficient 41 . Therefore, we modified this technique by directly injecting the liver of 3-day-old pups. To validate this approach, we utilized the TGW vector Figure 6C ). Additionally, hepcidin expression was significantly increased compared to the levels in Hfe-KO-Ctr mice ( Figure 6C ). This was reflected in a reduction in serum iron, transferrin saturation and liver iron content to levels which were almost normal ( Figures 6D, E, F) . However, this marked decrease in iron values did not produce major changes in their erythroid parameters compared to those seen in Hfe-KO-Ctr mice (Table 3) , suggesting an additional role for Hfe in the hematopoietic compartment.
Wt animals transplanted with Hfe-KO BM recover faster from erythropoietic stress than wt animals transplanted with wt BM
In order to further differentiate between the function of Hfe in the liver and that in the hematopoietic compartment, we performed a series of additional BMT experiments. The first two groups of animals were wt→wt (wt recipients engrafted with wt HSCs) and Hfe-KO→wt (wt recipients engrafted with Hfe-KO HSCs). These mice do not develop iron overload (Supplemental Table 2 ) allowing us to assess how the absence of Hfe in the hematopoietic compartment affects erythropoiesis in the absence of iron overload. As a further control for evaluating erythropoiesis in mice developing iron overload, we also generated wt→Hfe-KO (Hfe-KO recipients engrafted with wt HSCs), and Hfe-KO→Hfe-KO (Hfe-KO recipients engrafted with
Hfe-KO HSCs). When erythropoiesis was challenged by phlebotomy, we observed that wt→Hfe-KO and Hfe-KO→Hfe-KO animals recovered faster than Hfe-KO→wt and wt→wt mice ( Figures   7A and B) , supporting the hypothesis that lack of Hfe in the liver accelerates recovery when iron overload exists. Surprisingly, however, Hfe-KO→wt mice still had an increased response to anemia compared to wt→wt mice ( Figure 7A ). This was associated with an increased MCH and occurred despite the fact that these mice do not develop iron overload (Supplemental Table 2 ).
These data suggest that lack of Hfe in hematopoietic organs increases iron uptake by erythroid cells. Although this seems to be a mild effect it is sufficient to accelerate recovery from profound anemia under conditions of normal iron homeostasis. Additionally, iron absorption from the diet seems to be crucial for recovery from anemia, being a major source of iron in wt and Hfe-KO mice as demonstrated by a decreased response when mice were kept on a low iron diet. Phlebotomy is the main treatment for iron overload in HH patients. However, our data suggests that this treatment leads to both mobilization of iron from stores and increased intestinal iron absorption. These observations suggest that patients might benefit from a controlled iron diet or treatment with hepcidin/hepcidin agonists so as to limit iron absorption and thereby increase the benefit of the phlebotomy. We also determined that lack of
Hfe expression in the liver under pathological conditions prevents proper regulation of hepcidin in response to iron. We showed that th3→Hfe-KO mice had hepcidin levels similar to those of th3→wt mice despite increased iron overload, presenting a phenotype consistent with HH. This resulted in increased Hb production, with little effect on ineffective erythropoiesis (not shown).
3
All these data indicate that lack of an appropriate hepcidin response to iron overload is beneficial under conditions of stress erythropoiesis, where fast recovery from anemia is required. In beta-thalassemia, lack of Hfe is associated with increased Hb levels. This, however, also leads to increased iron overload that, over time, likely aggravates the overall phenotype in this disorder.
We also present evidences that some of the hematological differences could not be attributed exclusively to iron overload. 
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